Biggest News Aggregation in the World
📰 Twist Bioscience News

Page 39 - Twist Bioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Twist Bioscience. Real-time updates on events, politics, business and more.

Twist Bioscience launches enzymatic fragmentation kit

Twist Bioscience Corporation has launched the Twist Library Preparation Enzymatic Fragmentation Kit 2.0, a robust all-in-one solution designed to maximize accuracy and efficiency in library construction and amplification when conducting next-generation sequencing (NGS).
Emilym Leproust Library Preparation Twist Library Preparation Enzymatic Fragmentation Kit Library Preparation Enzymatic Fragmentation Kit Twist Bioscience Corporation Product News

Synthetic Biology Market worth $30.7 billion by 2026 - Exclusive Report by MarketsandMarkets™

The Factors such as a wide range of applications of synthetic biology, the rising R&D funding and growing initiatives in synthetic biology, declining cost of DNA sequencing and synthesizing, and increasing investments in the market are propelling the growth of this market. However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market. The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in ...
United States Asia Pacific Aashish Mehra Agilent Technologies Inc Product Service Consumables Technology Gene Synthesis

Twist Bioscience's Dr. Emily LeProust Disrupting the Future of Bioscience

Twist Bioscience’s Dr. Emily LeProust Disrupting the Future of Bioscience May 19, 2021 Female entrepreneurs are disrupting the traditionally male-dominated field of bioscience. One such disruptor is Dr. Emily Leproust, CEO and co-founder of Twist Bioscience (TWST), whose pioneering work on DNA-based applications and high-throughput DNA synthesis and sequencing is being used in everything from the fight against COVID-19 to brewing a better bottle of beer. “High-throughput DNA sequencing”...
Emily Leproust Bill Peck Agilent Technologies Fast Company Oligo Library Synthesis University Of Houston

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

New computer software to advance genome design capabilities

 E-Mail NEW YORK, May 12, 2021 -- A new Computer Aided Design (CAD) platform for whole genome design is being launched by two pioneers in the world of biotech: Genome Project-write (GP-write) and Twist Bioscience (NASDAQ: TWST). The technology is expected to open up new frontiers in genome research with real world applications to advance development of therapeutics and solutions for environmental health. The CAD technology will be an important development along the path to more facile writin...
Farren Isaacs Todd Peterson Douglas Densmore Genapex Bio Emily Leproust Amy Cayne Schwartz

CAD Platform Developed by GP-Write and Twist to Launch Large Genome Projects

CAD Platform Developed by GP-Write and Twist to Launch Large Genome Projects May 12, 2021 Share A new Computer Aided Design (CAD) platform for whole genome design is being launched by Genome Project-write (GP-write) and Twist Bioscience. The technology is expected to open up new frontiers in genome research with real-world applications to advance the development of therapeutics and solutions for environmental health. The CAD technology will be an important development along the path to more fac...
Emily Leproust George Church International Gene Synthesis Consortium Harvard Medical School Computer Aided Design Genome Project Write

Cathie Wood's Ark ETF sees 91% of holdings tumble in tech rout | FinancialContent Business Page

(Pixabay/Pexels) (Bloomberg) — Cathie Wood’s Ark Innovation ETF plunged to a six-month low, with all but five of its 58 holdings retreating in a broad tech selloff. The ARKK exchange-traded fund that makes concentrated bets on tech companies aiming to disrupt industries fell 5.2% Monday, double the loss in the Nasdaq 100 Index. It’s now down more than 30% from its February peak. Hardest hit in the portfolio listed in the fund’s May 7 holdings disclosure were two...
Pixabay Pexels Cathie Wood Ark Coinbase Global Inc Nanostring Technologies Inc Twist Bioscience Corp Twitter Inc

What Are the Risks With Twist Bioscience?

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights Twist Bioscience (NASDAQ:TWST) ranks as one of ARK Invest CEO Cathie Woods favorite genomics stocks right now. In this Motley Fool Live video recorded on April 21, 2021, Mot...
Cathie Wood Brian Orelli Keith Speights Cathy Wood Twist Bioscience Motley Fool Live
Source: fool.com

Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript

Welcome to Twist Bioscience Fiscal 2021 Second Quarter Financial Results Conference Call. [Operator Instructions] I would now like to turn the conference call over to Jim Thorburn, Chief Financial Officer. Jim Thorburn -- Chief Financial Officer Thank you, operator. Good afternoon, everyone. Id like to thank all of you for joining us today for Twist Bioscience conference call to review our fiscal 2021 second quarter financial results and business progress. We did issue our financial results ea...
South Africa Western Cape Emily Leproust Jim Thorburn Exchange Commission Twist Bioscience Corp
Source: fool.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science